Furthermore, dysregulation of IL1R2 has been detected in high‐grade squamous intraepithelial lesion (HSIL) and squamous cell carcinomas (SCC) in invasive cervical cancer, which ascertains its implication in cervical tumor progression (Niu et al., 2017). Here, IL1R2 is linked to uterine cervix neoplasm.